| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson.
Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $102,020 and 7, calls, for a total amount of $379,369.
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $160.0 for Johnson & Johnson, spanning the last three months.
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Johnson & Johnson's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Johnson & Johnson's substantial trades, within a strike price spectrum from $120.0 to $160.0 over the preceding 30 days.
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | SWEEP | BEARISH | 08/16/24 | $3.65 | $3.6 | $3.6 | $150.00 | $102.6K | 1.3K | 80 |
| JNJ | CALL | TRADE | BEARISH | 01/17/25 | $7.85 | $7.75 | $7.75 | $150.00 | $75.9K | 2.1K | 7 |
| JNJ | CALL | TRADE | BULLISH | 01/16/26 | $34.7 | $34.1 | $34.46 | $120.00 | $68.9K | 61 | 0 |
| JNJ | PUT | SWEEP | BULLISH | 10/18/24 | $2.0 | $1.99 | $1.99 | $140.00 | $59.7K | 878 | 3 |
| JNJ | PUT | SWEEP | BULLISH | 09/20/24 | $4.6 | $4.55 | $4.6 | $150.00 | $42.3K | 3.3K | 23 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
In the last month, 3 experts released ratings on this stock with an average target price of $188.33333333333334.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Johnson & Johnson options trades with real-time alerts from Benzinga Pro.
Posted In: JNJ
